In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions. 2018

Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
Department of Medical Parasitology and Mycology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran; Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: fakhiim.hamed@gmail.com.

In vitro interaction of voriconazole with micafungin was evaluated against 33 clinical Aspergillus fumigatus isolates, including azole-resistant (n=31) and -susceptible (n=2) isolates. Interaction was synergistic for only 1 resistant isolate carrying the TR34/L98H mutation. No antagonistic effects were observed for 96.8% of azole-resistant isolates.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077551 Micafungin A cyclic lipo-hexapeptide echinocandin antifungal agent that is used for the treatment and prevention of CANDIDIASIS. FK 463,FK-463,FK463,Micafungin Sodium,Mycamine
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001228 Aspergillosis Infections with fungi of the genus ASPERGILLUS. Aspergillus Infection,Aspergilloses,Aspergillus Infections,Infection, Aspergillus,Infections, Aspergillus
D001232 Aspergillus fumigatus A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals. Aspergillus fumigates,Neosartorya fumigata,Sartorya fumigata
D054714 Echinocandins Cyclic hexapeptides of proline-ornithine-threonine-proline-threonine-serine. The cyclization with a single non-peptide bond can lead them to be incorrectly called DEPSIPEPTIDES, but the echinocandins lack ester links. Antifungal activity is via inhibition of 1,3-beta-glucan synthase production of BETA-GLUCANS. Aculeacin,Echinocandin,Pneumocandin,Aculeacins,Mulundocandins,Pneumocandins
D055666 Lipopeptides Compounds consisting of a short peptide chain conjugated with an acyl chain. Lipopeptide,Anionic Lipopeptide,Anionic Lipopeptides,Cationic Lipopeptide,Cationic Lipopeptides,Lipopeptide, Anionic,Lipopeptide, Cationic,Lipopeptides, Anionic,Lipopeptides, Cationic
D025141 Drug Resistance, Fungal The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation. Antibiotic Resistance, Fungal,Antifungal Drug Resistance,Resistance, Antifungal Drug

Related Publications

Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
September 2020, The Journal of antimicrobial chemotherapy,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
April 2020, Emerging infectious diseases,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
January 2022, Frontiers in cellular and infection microbiology,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
August 2012, Antimicrobial agents and chemotherapy,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
January 2021, Revista iberoamericana de micologia,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
July 2015, Antimicrobial agents and chemotherapy,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
June 2012, Diagnostic microbiology and infectious disease,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
November 2018, The Journal of antimicrobial chemotherapy,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
March 2013, The Journal of antimicrobial chemotherapy,
Hamed Fakhim, and Afsane Vaezi, and Eric Dannaoui, and Cheshta Sharma, and Bita Mousavi, and Anuradha Chowdhary, and Jacques F Meis, and Hamid Badali
March 2005, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!